Format

Send to

Choose Destination
Otolaryngol Clin North Am. 2018 Dec;51(6):1179-1192. doi: 10.1016/j.otc.2018.07.013. Epub 2018 Sep 18.

Evaluation and Management of Facial Nerve Schwannoma.

Author information

1
Department of Otolaryngology, Otology, Neurotology, and Skull Base Surgery, Harvard Medical School, Massachusetts Eye and Ear, 243 Charles Street, Boston, MA 02114, USA. Electronic address: alicia_quesnel@meei.harvard.edu.
2
Department of Otolaryngology, Otology, Neurotology, and Skull Base Surgery, Harvard Medical School, Massachusetts Eye and Ear, 243 Charles Street, Boston, MA 02114, USA.

Abstract

Facial nerve schwannomas are benign peripheral nerve sheath tumors that arise from Schwann cells, and most commonly present with facial paresis and/or hearing loss. Computed tomography and MRI are critical to diagnosis. Management decisions are based on tumor size, facial function, and hearing status. Observation is usually the best option in patients with good facial function. For patients with poor facial function, the authors favor surgical resection with facial reanimation. There is growing evidence to support radiation treatment in patients with progressively worsening moderate facial paresis and growing tumors.

KEYWORDS:

Facial nerve schwannoma; Facial paresis; Management of facial nerve schwannoma

PMID:
30241764
DOI:
10.1016/j.otc.2018.07.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center